UEG Week Virtual 2021 Janssen-Sponsored Virtual Satellite Symposium: Targeting IL-12/23 in ulcerative colitis: from evidence to bedside

Review of the Janssen-Sponsored Virtual Satellite Symposium titled “Targeting IL-12/23 in ulcerative colitis: from evidence to bedside”, which took place at the UEG Week Virtual 2021 congress. This review covers the highlights from the presentations, providing a vital insight into the current landscape of ulcerative colitis.

Disclaimer: Sponsored by Janssen Pharmaceutical Companies of Johnson & Johnson in EMEA, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium